2m 2m 2m 2m 2m 2m 2m
Resmed (RMD)
NYSE
$231.50-$0.03 (-0.01%)
Price as of Aug 21, 2026 7:30 PM EDT- $33.4BMarket Cap
- -20.35%1-Year Change
- Medical Instruments & SuppliesIndustry
Resmed (RMD)
$231.50-$0.03 (-0.01%)
Annual
Quarterly
06/30/2026 | 06/30/2025 | 06/30/2024 | 06/30/2023 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 5.0B +10.49% | 4.5B -3.85% | 4.7B +10.95% | 4.2B +18.02% | |
Cost of Revenue | 2.2B +5.28% | 2.1B +3.02% | 2.0B +8.71% | 1.9B +20.18% | |
Gross Profit | 3.5B +12.99% | 3.1B +15.05% | 2.7B +12.72% | 2.4B +16.37% | |
Sales and Marketing Expense | 1.1B +12.97% | 991.0M +8.06% | 917.1M +4.94% | 874.0M +18.21% | |
Research and Development Expense | -378.3M +14.19% | -331.3M +7.73% | -307.5M +6.91% | -287.6M +13.43% | |
Depreciation and Amortization Expense | 201.3M +1.45% | 198.5M +12.21% | 176.9M +7.09% | 165.2M +3.48% | |
Total Operating Expenses | 1.6B +14.27% | 1.4B +2.56% | 1.3B +9.12% | 1.2B +19.51% | |
Operating Profit | 1.9B +11.95% | 1.7B +27.69% | 1.3B +16.61% | 1.1B +13.15% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | -45.7M -3.53% | -47.4M +112.35% | |
Interest Income and Expense and Net | 0 N/A | 0 +100.00% | -45.7M -3.53% | -47.4M +112.35% | |
Total Nonoperating Income and Expense | 32.7M +519.40% | -7.8M -85.85% | -55.1M +82.39% | -30.2M -24.11% | |
Income before Taxes | 1.9B +14.42% | 1.7B +32.64% | 1.3B +14.81% | 1.1B +14.70% | |
Income Taxes | 396.1M +43.09% | 276.8M +13.53% | 243.8M +19.47% | 204.1M +12.74% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | 2.3M 0.00% | |
Net Income | 1.5B +8.75% | 1.4B +37.20% | 1.0B +13.75% | 897.6M +15.15% | |
Net Income from Continuing Operations Applicable to Common | 1.9B +14.42% | 1.7B +32.64% | 1.3B +14.81% | 1.1B +14.70% | |
Basic EPS and Net Income | 10.47 +9.63% | 9.55 +37.61% | 6.94 +13.40% | 6.12 +14.61% | |
Diluted EPS and Net Income | 10.43 +9.67% | 9.51 +37.43% | 6.92 +13.63% | 6.09 +14.91% | |
Basic Weighted Average Shares | 145.5M -0.81% | 146.7M -0.21% | 147.0M +0.17% | 146.8M +0.48% | |
Diluted Weighted Average Shares | 146.1M -0.87% | 147.3M -0.14% | 147.6M +0.06% | 147.5M +0.28% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 1.5B +21.48% | 1.2B +407.40% | 238.4M +4.59% | 227.9M -16.74% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 1.5B +21.48% | 1.2B +407.40% | 238.4M +4.59% | 227.9M -16.74% | |
Total Current Assets | 4.3B +23.37% | 3.5B +48.69% | 2.4B -0.43% | 2.4B +22.59% | |
Accumulated Depreciation | 751.0M +6.48% | 705.3M -2.98% | 727.0M +8.83% | 668.0M +5.51% | |
Property and Plant and Equipment and Net | 581.8M +5.64% | 550.8M +0.50% | 548.0M +1.89% | 537.9M +7.96% | |
Total Long-Term Assets | 4.6B -0.59% | 4.7B +3.41% | 4.5B +2.98% | 4.4B +38.54% | |
Total Assets | 9.0B +9.68% | 8.2B +18.95% | 6.9B +1.79% | 6.8B +32.49% | |
Income Taxes Payable | 98.1M -25.83% | 132.3M +23.03% | 107.5M -1.73% | 109.4M +16.67% | |
Total Short-Term Debt | 259.9M +2,525.76% | 9.9M 0.00% | 9.9M -0.02% | 9.9M -0.14% | |
Total Current Liabilities | 1.4B +36.89% | 1.0B +11.91% | 910.7M +20.05% | 758.5M +10.04% | |
Total Long-Term Debt | 399.4M -39.33% | 658.4M -5.58% | 697.3M -51.28% | 1.4B +87.01% | |
Total Long-Term Liabilities | 985.4M -17.01% | 1.2B +8.17% | 1.1B -41.09% | 1.9B +78.17% | |
Total Liabilities | 2.4B +7.89% | 2.2B +9.87% | 2.0B -23.40% | 2.6B +51.10% | |
Retained Earnings | 7.3B +19.30% | 6.1B +21.83% | 5.0B +17.37% | 4.3B +17.69% | |
Total Stockholders Equity | 6.6B +10.35% | 6.0B +22.69% | 4.9B +17.78% | 4.1B +22.89% | |
Total Shares Outstanding | 144.2M -1.47% | 146.4M -0.35% | 146.9M -0.11% | 147.1M +0.45% | |
Cash Flow | |||||
Cash from Operating Activities | 1.8B +3.10% | 1.8B +25.00% | 1.4B +102.11% | 693.3M +97.44% | |
Capital Expenditures | 156.3M +73.91% | 89.9M -9.65% | 99.5M -16.89% | 119.7M -11.25% | |
Cash from Investing Activities | -545.2M +172.54% | -200.0M -25.85% | -269.8M -76.74% | -1.2B +404.46% | |
Dividends Paid | 349.7M +12.47% | 310.9M +10.12% | 282.3M +9.31% | 258.3M +5.27% | |
Cash from Financing Activities | -1.0B +66.11% | -606.3M -45.84% | -1.1B -364.69% | 422.9M +429.44% | |
Financials Ratio | |||||
Gross Margin | 55.77% +4.09% | 53.58% -5.47% | 56.67% +1.60% | 55.78% -1.40% | |
Operating Margin | 37.90% +1.32% | 37.41% +32.80% | 28.17% +5.11% | 26.80% -4.12% | |
Return on Assets | 17.77% -4.53% | 18.62% +24.23% | 14.99% -1.08% | 15.15% -4.51% | |
Return on Equity | 24.27% -6.16% | 25.86% +13.92% | 22.70% -5.26% | 23.96% -3.97% | |
Revenue Growth | 10.49% +372.53% | -3.85% -135.17% | 10.95% -39.26% | 18.02% +51.10% | |
Current Ratio | 3.10 -9.88% | 3.44 +32.86% | 2.59 -17.06% | 3.12 +11.40% | |
Cash Ratio | 1.05 -11.27% | 1.19 +353.50% | 0.26 -12.88% | 0.30 -24.35% | |
Debt-to-Equity Ratio | 0.10 -10.62% | 0.11 -22.97% | 0.15 -58.34% | 0.35 +51.28% | |
Debt-to-Assets Ratio | 0.07 -10.15% | 0.08 -20.51% | 0.10 -51.78% | 0.21 +40.30% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow